Liver metastases: Microenvironments and ex-vivo models

被引:100
|
作者
Clark, Amanda M. [1 ]
Ma, Bo [1 ]
Taylor, D. Lansing [2 ,3 ,4 ,5 ,6 ]
Griffith, Linda [7 ]
Wells, Alan [1 ,2 ,3 ,4 ,8 ]
机构
[1] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA
[5] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15213 USA
[6] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
[7] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[8] VA Pittsburgh Healthcare Syst, Pittsburgh VA Med Ctr, Pittsburgh, PA 15240 USA
关键词
Liver metastasis; metastatic models; tumor microenvironment; hepatic niche; microphysiological; HEPATIC STELLATE CELLS; COLON-CARCINOMA CELLS; MACROPHAGE-MEDIATED CYTOTOXICITY; EXPERIMENTAL MELANOMA METASTASIS; STIMULATED KUPFFER CELLS; E-CADHERIN EXPRESSION; TUMOR-NECROSIS-FACTOR; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL-CELLS;
D O I
10.1177/1535370216658144
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The liver is a highly metastasis-permissive organ, tumor seeding of which usually portends mortality. Its unique and diverse architectural and cellular composition enable the liver to undertake numerous specialized functions, however, this distinctive biology, notably its hemodynamic features and unique microenvironment, renders the liver intrinsically hospitable to disseminated tumor cells. The particular focus for this perspective is the bidirectional interactions between the disseminated tumor cells and the unique resident cell populations of the liver; notably, parenchymal hepatocytes and non-parenchymal liver sinusoidal endothelial, Kupffer, and hepatic stellate cells. Understanding the early steps in the metastatic seeding, including the decision to undergo dormancy versus outgrowth, has been difficult to study in 2D culture systems and animals due to numerous limitations. In response, tissue-engineered biomimetic systems have emerged. At the cutting-edge of these developments are ex vivo 'microphysiological systems' (MPS) which are cellular constructs designed to faithfully recapitulate the structure and function of a human organ or organ regions on a milli-to micro-scale level and can be made all human to maintain species-specific interactions. Hepatic MPSs are particularly attractive for studying metastases as in addition to the liver being a main site of metastatic seeding, it is also the principal site of drug metabolism and therapy-limiting toxicities. Thus, using these hepatic MPSs will enable not only an enhanced understanding of the fundamental aspects of metastasis but also allow for therapeutic agents to be fully studied for efficacy while also monitoring pharmacologic aspects and predicting toxicities. The review discusses some of the hepatic MPS models currently available and although only one MPS has been validated to relevantly modeling metastasis, it is anticipated that the adaptation of the other hepatic models to include tumors will not be long in coming.
引用
收藏
页码:1639 / 1652
页数:14
相关论文
共 50 条
  • [1] Ex-Vivo Characterization of Liver and Peritoneal Metastases by Confocal Laser Endomicroscopy: The PERSEE Project
    Pierangelo, Angelo
    Validire, Pierre
    Benali, Abdelali
    Fuks, David
    Abbaci, Muriel
    Dartigues, Peggy
    Laplace-Builhe, Corinne
    Gayet, Brice
    GASTROENTEROLOGY, 2015, 148 (04) : S1141 - S1141
  • [2] Ex-vivo normothermic liver perfusion: an update
    Vogel, Thomas
    Brockmann, Jens G.
    Friend, Peter J.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (02) : 167 - 172
  • [3] Ex-Vivo Pharmacological Defatting of the Liver: A Review
    Goumard, Claire
    Turco, Celia
    Sakka, Mehdi
    Aoudjehane, Lynda
    Lesnik, Philippe
    Savier, Eric
    Conti, Filomena
    Scatton, Olivier
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 11
  • [4] Normothermic and subnormothermic ex-vivo liver perfusion in liver transplantation
    Goldaracena, Nicolas
    Barbas, Andrew S.
    Selzner, Markus
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2016, 21 (03) : 315 - 321
  • [5] Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments
    Muenst, S.
    Muraro, M.
    Mele, V.
    Quagliata, L.
    Iezzi, G.
    Tzankov, A.
    Weber, W.
    Spagnoli, G.
    Soysal, S.
    VIRCHOWS ARCHIV, 2017, 471 : S24 - S24
  • [6] WARM ISCHEMIC LIVER IN EX-VIVO PERFUSION OF PIG
    BAKER, PR
    CUSCHIER.A
    SHIELDS, R
    EUROPEAN SURGICAL RESEARCH, 1972, 4 (4-5) : 248 - 248
  • [7] Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments
    Muraro, Manuele G.
    Muenst, Simone
    Mele, Valentina
    Quagliata, Luca
    Iezzi, Giandomenica
    Tzankov, Alexandar
    Weber, Walter P.
    Spagnoli, Giulio C.
    Soysal, Savas D.
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [8] Development of Ex-Vivo Models of Metastatic Neuroendocrine Neoplasms
    Srirajaskanthan, R.
    Doornebal, E.
    Harris, N.
    Zen, Y.
    Pizanias, M.
    Prachalias, A.
    Zamalloa, A.
    Heat, N.
    Williams, R.
    Palma, E.
    Chokshi, S.
    Srirajaskanthan, R.
    NEUROENDOCRINOLOGY, 2020, 110 : 31 - 31
  • [9] Human Pancreatitis Organellar Disorders: Ex-Vivo Models
    Lugea, A.
    Groblewski, G.
    Waldron, R. T.
    Messenger, S.
    Thomas, D. D.
    Jones, E.
    Su, H. -Y.
    Mareninova, O. A.
    Gretler, S.
    Yang, J.
    Gukovsky, I.
    Gukovskaya, A. S.
    Gorelick, F.
    Pandol, S. J.
    PANCREAS, 2016, 45 (10) : 1521 - 1521
  • [10] Pharmacogenomics in liver transplantation: testing the recipient and the ex-vivo donor liver
    Kisor, David F.
    Bodzin, Adam S.
    PHARMACOGENOMICS, 2018, 19 (09) : 753 - 756